BRCA2 and prostate cancer: According to the European Association of Urology guidelines, which apply in Poland, it should include men from 50 years of age, men from 45 years of age and a family history of prostate cancer, men carrying BRCA2 mutations from 40 years of age, and men of African descent from 45 years of age [24].